NCT02921802View on ClinicalTrials.gov

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

CompletedOBSERVATIONAL

Enrollment

4,626

Participants

Timeline

Start Date

July 20, 2010

Primary Completion Date

March 29, 2013

Study Completion Date

March 29, 2013

Conditions

Multiple MyelomaMyelodysplastic Syndromes

Trial Locations (1)

651-0072

Shinko Hospital, Kobe

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY